HO2 — DR Horton Cashflow Statement
0.000.00%
- €38.79bn
- €41.80bn
- $34.25bn
- 52
- 48
- 54
- 49
Annual cashflow statement for DR Horton, fiscal year end - September 30th, USD millions except per share, conversion factor applied.
2021 September 30th | 2022 September 30th | 2023 September 30th | 2024 September 30th | 2025 September 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 4,191 | 5,896 | 4,795 | 4,806 | 3,621 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 131 | 176 | 192 | 197 | 289 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -3,852 | -5,620 | -728 | -2,919 | -714 |
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | 534 | 562 | 4,304 | 2,190 | 3,421 |
| Capital Expenditures | -267 | -148 | -149 | -165 | -137 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 15.2 | -267 | -162 | -25.3 | -31.3 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -252 | -415 | -310 | -191 | -169 |
| Financing Cash Flow Items | -80.9 | 29.4 | -111 | -108 | -8.7 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -85.1 | -811 | -2,667 | -1,355 | -4,763 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 197 | -664 | 1,327 | 644 | -1,511 |